Ronald Blue Trust, Inc. Prothena Corp Public LTD CO Transaction History
Ronald Blue Trust, Inc.
- $7.7 Billion
- Q4 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 711 shares of PRTA stock, worth $10,117. This represents 0.0% of its overall portfolio holdings.
Number of Shares
711
Previous 624
13.94%
Holding current value
$10,117
Previous $8,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PRTA
# of Institutions
185Shares Held
42.8MCall Options Held
162KPut Options Held
102K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$165 Million8.41% of portfolio
-
Wellington Management Group LLP Boston, MA4.18MShares$59.5 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$54.9 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$54.4 Million0.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.74MShares$24.7 Million4.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $668M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...